SEC Form D · filed January 8, 2021
Cellectar Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Frederick W. Driscoll · Florham Park, NJDirectorDouglas J. Swirsky · Florham Park, NJDirectorStephen A. Hill · Florham Park, NJDirectorJames V. Caruso · Florham Park, NJExec · DirectorJarrod J. Longcor · Florham Park, NJExecJohn A. Neis · Florham Park, NJDirectorStefan A. Loren · Florham Park, NJDirectorMichel Paris · Paris, I0DirectorDain N. Zaitz · WILSONVILLE, ORExecJeremy Abelson · denver, CODirectorDah Hui Lau · Singapore, U0Exec · DirectorChristopher N. Crow · WILSONVILLE, ORDirectorVincent Charuel · Luxembourg, LuxembourgDirectorPatrick Mouterde · Paris, I0DirectorDov Elefant · New York, NYExecJohn J. Friend · Florham Park, NJDirectorTodd Dagres · Hampton, NHExec · DirectorJeffrey Morin · Hampton, NHDirectorMariano Suarez-Battan · San Francisco, CAExecWeston Gaddy · New York, NYDirectorJeff Lieberman · San Francisco, CADirectorPatricio Jutard · San Francisco, CADirectorSimon Cox · SINGAPORE, U0DirectorDov Elefant · London, United KingdomExecJohn J. Friend · Florham Park, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗